相关实验视频
Updated: Sep 13, 2025

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
1.3K
在患有轻度阿尔茨海默氏病的患者中,认知刺激小组计划的效果
1Department of Occupational Therapy, Davinci Hospital, Daejeon, Republic of Korea.
The British journal of occupational therapy
|August 1, 2025
概括
一个认知刺激小组计划改善了认知功能,减少了抑郁症,并改善了轻度阿尔茨海默病患者的日常生活活动和生活质量.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 轻度阿尔茨海默氏症 (AD) 在认知功能,情绪和日常生活中带来了挑战.
- 有效的干预措施对于管理症状和改善阿兹海默症患者的生活质量至关重要.
研究的目的:
- 评估认知刺激小组计划对认知功能,抑郁症,日常生活活动 (ADL) 和轻度AD患者生活质量的影响.
主要方法:
- 60名患有轻度阿尔茨海默病的患者随机分配到实验组 (认知刺激计划) 或对照组 (认知工作簿).
- 两组都接受了传统的职业治疗,随后进行了各自的50分钟小组会议.
- 干预每天进行4周,每周5次.
主要成果:
- 与对照组相比,实验组在记忆,命名,口头学习和执行功能方面表现出明显的改善.
- 认知刺激计划导致实验组中抑郁症得分显著降低.
- 在实验组的日常生活工具活动 (IADL) 和整体生活质量方面也观察到改善.
结论:
- 认知刺激小组计划是对轻度阿尔茨海默病的有效干预措施.
- 这些程序可以增强认知功能,减少抑郁症,改善日常生活和生活质量.
- 该研究为未来的AD治疗策略提供了指导方针,强调积极参与和动机.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
208
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
208
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Cognitive Development During Adulthood
282
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
282
Dementia
166
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
166

